Clinical trial
Feasibility of Unsupervised Therapy After Stroke in the Home Setting With a Hand Rehabilitation Device (ReHandyBot): an Exploratory Study
NCT06057129 is registered in ClinicalTrials.gov with Swiss Federal Institute of Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Unsupervised Therapy After Stroke in the Home Setting With a Hand Rehabilitation Device (ReHandyBot): an Exploratory Study
- Lead sponsor
- Swiss Federal Institute of Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 13, 2023
- Completion date
- May 29, 2026
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.